Home LiteratureArticle Details
PMID: 14963115 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities.

Journal of virology ·Vol. 78 ·No. 5 ·2004-03-00 ·Pages 2187-200

Frahm N, Korber BT, Adams CM, Szinger JJ, Draenert R, Addo MM, Feeney ME, Yusim K, Sango K, Brown NV, SenGupta D, Piechocka-Trocha A, Simonis T, Marincola FM, Wurcel AG, Stone DR, Russell CJ, Adolf P, Cohen D, Roach T, StJohn A, Khatri A, Davis K, Mullins J, Goulder PJ, Walker BD, Brander C

Abstract

Although there is increasing evidence that virus-specific cytotoxic-T-lymphocyte (CTL) responses play an important role in the control of human immunodeficiency virus (HIV) replication in vivo, only scarce CTL data are available for the ethnic populations currently most affected by the epidemic. In this study, we examined the CD8(+)-T-cell responses in African-American, Caucasian, Hispanic, and Caribbean populations in which clade B virus dominates and analyzed the potential factors influencing immune recognition. Total HIV-specific CD8(+)-T-cell responses were determined by enzyme-linked immunospot assays in 150 HIV-infected individuals by using a clade B consensus sequence peptide set spanning all HIV proteins. A total of 88% of the 410 tested peptides were recognized, and Nef- and Gag-specific responses dominated the total response for each ethnicity in terms of both breadth and magnitude. Three dominantly targeted regions within these proteins that were recognized by >90% of individuals in each ethnicity were identified. Overall, the total breadth and magnitude of CD8(+)-T-cell responses correlated with individuals' CD4 counts but not with viral loads. The frequency of recognition for each peptide was highly correlated with the relative conservation of the peptide sequence, the presence of predicted immunoproteasomal cleavage sites within the C-terminal half of the peptide, and a reduced frequency of amino acids that impair binding of optimal epitopes to the restricting class I molecules. The present study thus identifies factors that contribute to the immunogenicity of these highly targeted and relatively conserved sequences in HIV that may represent promising vaccine candidates for ethnically heterogeneous populations.

MeSH Terms
AIDS Vaccines African Americans/genetics Amino Acid Sequence Anti-Retroviral Agents/pharmacology CD4 Lymphocyte Count Cells, Cultured Entropy Ethnicity/genetics Gene Frequency HIV/chemistry,drug effects,immunology HIV Antigens/chemistry,immunology Hispanic or Latino/genetics Histocompatibility Antigens Class I/genetics,immunology Humans Immunodominant Epitopes/chemistry,immunology Molecular Sequence Data T-Lymphocytes, Cytotoxic/immunology Viral Load
Chemicals
AIDS Vaccines Anti-Retroviral Agents HIV Antigens Histocompatibility Antigens Class I Immunodominant Epitopes
Authors & Affiliations
27 authors, click to expand affiliations / ORCID
Frahm Nicole
Partners AIDS Research Center, Endocrine Unit, Massachusetts General Hospital, Charlestown, Massachusetts 02129-2000, USA.
Korber B T
Adams C M
Szinger J J
Draenert R
Addo M M
Feeney M E
Yusim K
Sango K
Brown N V
SenGupta D
Piechocka-Trocha A
Simonis T
Marincola F M
Wurcel A G
Stone D R
Russell C J
Adolf P
Cohen D
Roach T
StJohn A
Khatri A
Davis K
Mullins J
Goulder P J R
Walker B D
Brander C
References (49)
49 references, click to expand
  1. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Science. 2002 May 24;296(5572):1439-43 PMID: 12029127
  2. Prediction of proteasome cleavage motifs by neural networks.
    Protein Eng. 2002 Apr;15(4):287-96 PMID: 11983929
  3. HIV: current opinion in escapology.
    Curr Opin Microbiol. 2002 Aug;5(4):408-13 PMID: 12160861
  4. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
    J Virol. 2002 Sep;76(17):8757-68 PMID: 12163596
  5. Design and tests of an HIV vaccine.
    Br Med Bull. 2002;62:87-98 PMID: 12176852
  6. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.
    J Virol. 2002 Oct;76(20):10155-68 PMID: 12239290
  7. Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.
    J Virol. 2002 Dec;76(24):12414-22 PMID: 12438567
  8. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
    J Infect Dis. 2002 Dec 1;186(11):1589-96 PMID: 12447734
  9. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
    Nature. 2002 Nov 28;420(6914):434-9 PMID: 12459786
  10. Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.
    AIDS. 2002 Dec 6;16(18):2399-407 PMID: 12461413
  11. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.
    J Virol. 2003 Jan;77(2):882-90 PMID: 12502804
  12. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    J Virol. 2003 Feb;77(3):2081-92 PMID: 12525643
  13. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    J Immunol Methods. 2003 Apr 1;275(1-2):19-29 PMID: 12667667
  14. Requirement for CD4 T cell help in generating functional CD8 T cell memory.
    Science. 2003 Apr 11;300(5617):337-9 PMID: 12690201
  15. Defective CD8 T cell memory following acute infection without CD4 T cell help.
    Science. 2003 Apr 11;300(5617):339-42 PMID: 12690202
  16. Early and late cytotoxic T lymphocyte responses in HIV infection.
    AIDS. 2002;16 Suppl 4:S97-103 PMID: 12699006
  17. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    J Virol. 2003 Jun;77(12):6867-78 PMID: 12768006
  18. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.
    J Virol. 2003 Jul;77(13):7330-40 PMID: 12805431
  19. Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.
    J Virol. 2003 Jul;77(13):7492-501 PMID: 12805449
  20. Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities.
    J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):426-38 PMID: 12869831
  21. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Nature. 1987 Jul 23-29;328(6128):345-8 PMID: 3496541
  22. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.
    Science. 1993 Nov 19;262(5137):1257-61 PMID: 8235655
  23. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences.
    J Virol. 1994 Nov;68(11):7467-81 PMID: 7933130
  24. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
    Nat Med. 1996 Apr;2(4):405-11 PMID: 8597949
  25. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).
    Tissue Antigens. 1995 Nov;46(5):355-67 PMID: 8838344
  26. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
    J Gen Virol. 1997 Aug;78 ( Pt 8):1913-8 PMID: 9266987
  27. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
    Science. 1998 Mar 27;279(5359):2103-6 PMID: 9516110
  28. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    J Immunol. 1999 Feb 1;162(3):1780-8 PMID: 9973442
  29. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
    J Virol. 1999 Aug;73(8):6721-8 PMID: 10400770
  30. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.
    J Virol. 1999 Sep;73(9):7108-16 PMID: 10438796
  31. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
    Curr Opin Immunol. 1999 Aug;11(4):451-9 PMID: 10448136
  32. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  33. Advantage of rare HLA supertype in HIV disease progression.
    Nat Med. 2003 Jul;9(7):928-35 PMID: 12819779
  34. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
    J Virol. 2000 Jun;74(12):5679-90 PMID: 10823876
  35. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.
    J Immunol. 2000 Jul 15;165(2):1082-92 PMID: 10878387
  36. Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype.
    J Virol. 2000 Oct;74(19):9144-51 PMID: 10982361
  37. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Science. 2000 Oct 20;290(5491):486-92 PMID: 11039923
  38. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
    Mol Med. 2000 Sep;6(9):803-9 PMID: 11071274
  39. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.
    J Exp Med. 2000 Dec 18;192(12):1819-32 PMID: 11120778
  40. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
    Science. 2001 Apr 6;292(5514):69-74 PMID: 11393868
  41. Evolution and transmission of stable CTL escape mutations in HIV infection.
    Nature. 2001 Jul 19;412(6844):334-8 PMID: 11460164
  42. HLA and AIDS: a cautionary tale.
    Trends Mol Med. 2001 Sep;7(9):379-81 PMID: 11530315
  43. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations.
    Hum Immunol. 2001 Sep;62(9):1009-30 PMID: 11543903
  44. Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development?
    Immunol Lett. 2001 Nov 1;79(1-2):77-84 PMID: 11595292
  45. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    J Virol. 2001 Dec;75(24):11983-91 PMID: 11711588
  46. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Nature. 2002 Jan 17;415(6869):331-5 PMID: 11797011
  47. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.
    J Virol. 2002 Mar;76(5):2298-305 PMID: 11836408
  48. Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection.
    J Clin Invest. 2002 Mar;109(6):837-43 PMID: 11901192
  49. Diversity considerations in HIV-1 vaccine selection.
    Science. 2002 Jun 28;296(5577):2354-60 PMID: 12089434
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-03-00
Pages
2187-200
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC369231
Subset
IM
Grants
PHS HHS · N01-A1-15422 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com